NL-OMON33417尚未招募不适用
A prospective multi-national randomized comparison of the effectiveness and safety of MiniArc and Monarc. - MiniMo-trial.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Female symptomatic stress urinary incontinence resulting from urethral hypermobility and/or ISD (intrinsic sphincter deficiency).
排除标准
- •1. Subjects who have stage 2 or more genital prolaps, according to the ICS-classification
- •2. Subjects who undergo surgery for recurrence of stress incontinence
- •3. Subjects who undergo concomitant surgical procedures
- •4. Subjects who are pregnant or want to become pregnant
- •5. Subjects are not capable of giving informed consent
研究者
相似试验
已完成
不适用
MiniMo-trial.NL-OMON29267Academic Medical CenterMeibergdreef 91105 AZ AmsterdamThe Netherlands192
已完成
不适用
Multinational comparison analysis using quantitative radiological evaluation in MAC pulmonary disease (MACPD)Mycobacterium avium complex pulmonary disease (MAC-PD)JPRN-UMIN000017930TM-NET (NONTUBERCULOUS MYCOBACTERIA NETWORK EUROPOEAN TRIALGROUP)80
进行中（未招募）
不适用
Comparación multinacional, abierta, aleatorizada, de grupos paralelos, con un periodo de prueba de 4 semanas y 26 semanas de tratamiento hasta conseguir el objetivo, de insulina aspart bifásica 30 una vez al día frente a insulina glargina una vez al día, ambas en combinación con metformina y con glimepirida, en pacientes con diabetes tipo 2 que no han recibido tratamiento con insulinaEUCTR2006-003288-29-ESovo Nordisk A/S700
暂停
不适用
efficacy and safety of Ciclesonide, metered-dose inhalerCTRI/2020/09/027824PSK Pharma LLC
尚未招募
3 期
Glycopyrronium bromide 50 μg inhalation powder capsulesCTRI/2021/11/038151PSK Pharma LLC